Benitec Biopharma Inc. (NASDAQ:BNTC)
| Market Cap | $313.86M-31.6% |
| Revenue (ttm) | $0 |
| Net Income | -$49.51M-18.4% |
| EPS | -$1.03+21.4% |
| Shares Out | 34.89M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Jun 1, 2018 |
| Volume | 6,923.554 |
| Open | $9.17 |
| Previous Close | $9.09 |
| Day's Range | $8.69 - $9.36 |
| 52-Week Range | $7.88 - $14.39 |
| Beta | 0.25 |
| Analysts | Buy |
| Price Target | $15.50(+72.30%) |
| Earnings Date | Nov 13, 2026 |
About BNTC
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
1 firm rating BNTC in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Nov 13, 2026Earnings report
$BNTC stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in BNTC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by BNTC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
BNTC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New BNTC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to BNTC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in BNTC
| PINKSimplify Health Care ETF | $12.49M |
| VTIVanguard Morningstar Total Stock Market ETF | $6.50M |
| IWMiShares Russell 2000 ETF | $5.03M |
| VXFVanguard Extended Market ETF | $3.63M |
| IWNiShares Russell 2000 Value ETF | $1.78M |
| VTWOVanguard Russell 2000 ETF | $1.24M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from BNTC’s recent data — informational, not investment advice